(Q38636217)

5 September 2017

title

Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development (English)

1 reference

5 September 2017

0 references

1 reference

2

Ralf Bartenschlager

1 reference

5 September 2017

Eliana G Acosta

1

1 reference

5 September 2017

publication date

17 November 2015

1 reference

Expert Review of Vaccines

5 September 2017

published in

1 reference

5 September 2017

volume

15

1 reference

5 September 2017

issue

4

1 reference

5 September 2017

page(s)

467-482

1 reference

Update on the global spread of dengue

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

The global distribution and burden of dengue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

The origin, emergence and evolutionary genetics of dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Dengue--quo tu et quo vadis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Human skin Langerhans cells are targets of dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Shock associated with dengue infection. I. Clinical and physiologic manifestations of dengue hemorrhagic fever in Thailand, 1964.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

A structural perspective of the flavivirus life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

A ligand-binding pocket in the dengue virus envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Biophysical Characterization and Vector-Specific Antagonist Activity of Domain III of the Tick-Borne Flavivirus Envelope Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Structure of the dengue virus envelope protein after membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Structure of acidic pH dengue virus showing the fusogenic glycoprotein trimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Revisiting dengue virus-host cell interaction: new insights into molecular and cellular virology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Dengue virus- and hepatitis C virus-induced replication and assembly compartments: the enemy inside--caught in the web.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Composition and three-dimensional architecture of the dengue virus replication and assembly sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Ultrastructural characterization and three-dimensional architecture of replication sites in dengue virus-infected mosquito cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Structures of immature flavivirus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Structure of Immature West Nile Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

The stem region of premembrane protein plays an important role in the virus surface protein rearrangement during dengue maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Structure of the immature dengue virus at low pH primes proteolytic maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Functional importance of dengue virus maturation: infectious properties of immature virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Association of the pr Peptides with Dengue Virus at Acidic pH Blocks Membrane Fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Structural Changes in Dengue Virus When Exposed to a Temperature of 37 C

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Dengue structure differs at the temperatures of its human and mosquito hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Near-Atomic Resolution Cryo-Electron Microscopic Structure of Dengue Serotype 4 Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Retrospective study of Western blot profiles in immune sera of natural dengue virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Cross-reacting antibodies enhance dengue virus infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Differential Modulation of prM Cleavage, Extracellular Particle Distribution, and Virus Infectivity by Conserved Residues at Nonfurin Consensus Positions of the Dengue Virus pr-M Junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Maturation of flaviviruses starts from one or more icosahedrally independent nucleation centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Neutralization and antibody-dependent enhancement of dengue viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

In Vivo Enhancement of Dengue Virus Infection in Rhesus Monkeys by Passively Transferred Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Role of dendritic cells in antibody-dependent enhancement of dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Immature Dengue Virus: A Veiled Pathogen?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Ligation of Fc gamma receptor IIB inhibits antibody-dependent enhancement of dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

A fusion-loop antibody enhances the infectious properties of immature flavivirus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Development of an antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing Fc gammaRIIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Differential Enhancement of Dengue Virus Immune Complex Infectivity Mediated by Signaling-Competent and Signaling-Incompetent Human Fc RIA (CD64) or Fc RIIA (CD32)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Flavivirus entry receptors: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Receptors and routes of dengue virus entry into the host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Gulping rather than sipping: macropinocytosis as a way of virus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Virus entry by endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Functional entry of dengue virus into Aedes albopictus mosquito cells is dependent on clathrin-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Infectious dengue-1 virus entry into mosquito C6/36 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Endocytic pathway followed by dengue virus to infect the mosquito cell line C6/36 HT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Rab 5 is required for the cellular entry of dengue and West Nile viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Small interference RNA profiling reveals the essential role of human membrane trafficking genes in mediating the infectious entry of dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Alternative infectious entry pathways for dengue virus serotypes into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Dengue virus ensures its fusion in late endosomes using compartment-specific lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Differential requirements in endocytic trafficking for penetration of dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Flavivirus infection enhancement in macrophages: an electron microscopic study of viral cellular entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Differential role of actin, clathrin, and dynamin in Fc gamma receptor-mediated endocytosis and phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

How innate immune mechanisms contribute to antibody-enhanced viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Structural basis of West Nile virus neutralization by a therapeutic antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

An Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Structural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-Reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Structural insights into the neutralization mechanism of a higher primate antibody against dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Humoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle Antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Sculpting humoral immunity through dengue vaccination to enhance protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

A highly conserved region between amino acids 221 and 266 of dengue virus non-structural protein 1 is a major epitope region in infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Serotype-specific anti-Dengue virus NS1 mouse antibodies cross-react with prM and are potentially involved in virus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

B-cell responses during primary and secondary dengue virus infections in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Synergistic Interactions of Anti-NS1 Monoclonal Antibodies Protect Passively Immunized Mice from Lethal Challenge with Dengue 2 Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

The structural basis for serotype-specific neutralization of dengue virus by a human antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Recognition determinants of broadly neutralizing human antibodies against dengue viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2-11 years in Malaysia: a randomized, placebo-controlled, Phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Efficacy of a tetravalent dengue vaccine in children in Latin America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Antibodies against immature virions are not a discriminating factor for dengue disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Discrepancy in Dengue Virus Neutralizing Antibody Titers between Plaque Reduction Neutralizing Tests with Fc Receptor (Fc R)-Negative and Fc R-Expressing BHK-21 Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Genotype-specific neutralization and protection by antibodies against dengue virus type 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

Dengue vaccines: recent developments, ongoing challenges and current candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1121814

10.1586/14760584.2016.1121814

21 January 2018

Identifiers

DOI

1 reference

5 September 2017

1 reference